The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Advances in targeting cyclic nucleotide phosphodiesterases
Open accessAbstract
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides, their signalling pathways and, consequently, myriad biological responses in health and disease. Currently, a small number of PDE inhibitors are used clinically for treating the pathophysiological dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease. However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J., & Houslay, M. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262787199 · Cited by 360
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Cardiac excitation–contraction coupling
Bers, D. M. (2002) · Nature · doi:10.1038/415198a · Cited by 4,744
Hartong, D. T., Berson, E. L., & Dryja, T. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69740-7 · Cited by 2,924
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Self-citationConti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
FORMATION OF A CYCLIC ADENINE RIBONUCLEOTIDE BY TISSUE PARTICLES
Rall, T. W., & Sutherland, E. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77422-5 · Cited by 831
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S. T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S. M., Einarsson, O. B., Gudjonsdottir, H. M., et al. (2003) · Nature Genetics · doi:10.1038/ng1245 · Cited by 564
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways
Dodge-Kafka, K. L., Soughayer, J., Pare, G. C., Carlisle Michel, J. J., Langeberg, L. K., Kapiloff, M. S., & Scott, J. D. (2005) · Nature · doi:10.1038/nature03966 · Cited by 556
Behavioral phenotypes of Disc1 missense mutations in mice
Clapcote, S. J., Lipina, T. V., Millar, J. K., Mackie, S., Christie, S., Ogawa, F., Lerch, J. P., Trimble, K., Uchiyama, M., Sakuraba, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.015 · Cited by 526
Lehnart, S. E., Wehrens, X. H. T., Reiken, S., Warrier, S., Belevych, A. E., Harvey, R. D., Richter, W., Jin, S.-L. C., Conti, M., & Marks, A. R. (2005) · Cell · doi:10.1016/j.cell.2005.07.030 · Cited by 517
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
A genetically encoded, fluorescent indicator for cyclic AMP in living cells
Zaccolo, M., De Giorgi, F., Cho, C. Y., Feng, L., Knapp, T., Negulescu, P. A., Taylor, S. S., Tsien, R. Y., & Pozzan, T. (2000) · Nature Cell Biology · doi:10.1038/71345 · Cited by 485
Structure and Regulation of Soluble Guanylate Cyclase
Derbyshire, E. R., & Marletta, M. A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-050410-100030 · Cited by 466
Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes.
Buxton, I. L., & Brunton, L. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44447-4 · Cited by 440
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Card, G. L., England, B. P., Suzuki, Y., Fong, D., Powell, B., Lee, B., Luu, C., Tabrizizad, M., Gillette, S., Ibrahim, P. N., et al. (2004) · Structure · doi:10.1016/j.str.2004.10.004 · Cited by 432
Burgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1598 · Cited by 397
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Jurevicius, J., & Fischmeister, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.295 · Cited by 373
Jin, S.-L. C., & Conti, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122041599 · Cited by 367
Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352
To, Y., Ito, K., Kizawa, Y., Failla, M., Ito, M., Kusama, T., Elliott, W. M., Hogg, J. C., Adcock, I. M., & Barnes, P. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0937oc · Cited by 352
Maurice, D. H., & Haslam, R. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10974-7 · Cited by 351
Self-citationImmunohistochemical localization of PDE10A in the rat brain
Seeger, T. F., Bartlett, B., Coskran, T. M., Culp, J. S., James, L. C., Krull, D. L., Lanfear, J., Ryan, A. M., Schmidt, C. J., Strick, C. A., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02754-9 · Cited by 334
Houslay, M. D., Baillie, G. S., & Maurice, D. H. (2007) · Circulation Research · doi:10.1161/01.res.0000261934.56938.38 · Cited by 317
Self-citationYarwood, S. J., Steele, M. R., Scotland, G., Houslay, M. D., & Bolger, G. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14909 · Cited by 306
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
Lugnier, C., Schoeffter, P., Le Bec, A., Strouthou, E., & Stoclet, J. C. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90333-3 · Cited by 301
A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases
Zhang, K. Y. J., Card, G. L., Suzuki, Y., Artis, D. R., Fong, D., Gillette, S., Hsieh, D., Neiman, J., West, B. L., Zhang, C., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.005 · Cited by 300
Coronary Stent Restenosis in Patients Treated With Cilostazol
Douglas, J. S., Holmes, D. R., Kereiakes, D. J., Grines, C. L., Block, E., Ghazzal, Z. M. B., Morris, D. C., Liberman, H., Parker, K., Jurkovitz, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.530097 · Cited by 281
Mongillo, M., Tocchetti, C. G., Terrin, A., Lissandron, V., Cheung, Y.-F., Dostmann, W. R., Pozzan, T., Kass, D. A., Paolocci, N., Houslay, M. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000200178.34179.93 · Cited by 278
Rabe, K. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01218.x · Cited by 273
Grauer, S. M., Pulito, V. L., Navarra, R. L., Kelly, M. P., Kelley, C., Graf, R., Langen, B., Logue, S., Brennan, J., Jiang, L., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155994 · Cited by 269
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15506 · Cited by 267
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Reneerkens, O. A. H., Rutten, K., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1273-x · Cited by 266
Cyclic nucleotide phosphodiesterase 3A–deficient mice as a model of female infertility
Masciarelli, S., Horner, K., Liu, C., Park, S. H., Hinckley, M. D., Hockman, S. C., Nedachi, T., Jin, C., Conti, M., & Manganiello, V. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421804 · Cited by 261
Self-citationRobichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215506 · Cited by 259
Specific Role of Phosphodiesterase 4B in Lipopolysaccharide-Induced Signaling in Mouse Macrophages
Jin, S.-L. C., Lan, L., Zoudilova, M., & Conti, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1523 · Cited by 255
Weishaar, R. E., Cain, M. H., & Bristol, J. A. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm50001a001 · Cited by 248
Phosphodiesterase inhibitors in airways disease
Fan Chung, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.059 · Cited by 243
Thompson, W. J., Terasaki, W. L., Epstein, P. M., & Sj, S. (1979) · PubMed · Cited by 242
Zhao, A. Z., Huan, J.-N., Gupta, S., Pal, R., & Sahu, A. (2002) · Nature Neuroscience · doi:10.1038/nn885 · Cited by 242
Wachtel, H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90239-3 · Cited by 240
Andersson, K., de Groat, W. C., McVary, K. T., Lue, T. F., Maggi, M., Roehrborn, C. G., Wyndaele, J. J., Melby, T., & Viktrup, L. (2011) · Neurourology and Urodynamics · doi:10.1002/nau.20999 · Cited by 226
Capturing adenylyl cyclases as potential drug targets
Pierre, S., Eschenhagen, T., Geisslinger, G., & Scholich, K. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2827 · Cited by 224
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
Archer, S. L., & Michelakis, E. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0904473 · Cited by 224
MacFarland, R. T., Zelus, B. D., & Beavo, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52413-3 · Cited by 222
Verde, I., Pahlke, G., Salanova, M., Zhang, G., Wang, S., Coletti, D., Onuffer, J., Jin, S.-L. C., & Conti, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006546200 · Cited by 217
The Antidepressant and Antiinflammatory Effects of Rolipram in the Central Nervous System
Zhu, J., Mix, E., & Winblad, B. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00206.x · Cited by 215
Card, G. L., Blasdel, L., England, B. P., Zhang, C., Suzuki, Y., Gillette, S., Fong, D., Ibrahim, P. N., Artis, D. R., Bollag, G., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1059 · Cited by 208
Verhoest, P. R., Chapin, D. S., Corman, M., Fonseca, K., Harms, J. F., Hou, X., Marr, E. S., Menniti, F. S., Nelson, F., O’Connor, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900521k · Cited by 205
Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ
Perino, A., Ghigo, A., Ferrero, E., Morello, F., Santulli, G., Baillie, G. S., Damilano, F., Dunlop, A. J., Pawson, C., Walser, R., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.030 · Cited by 200
Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors
Minguet, S., Huber, M., Rosenkranz, L., Schamel, W. W. A., Reth, M., & Brummer, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200425524 · Cited by 197
Resveratrol as a calorie restriction mimetic: therapeutic implications
Chung, J. H., Manganiello, V., & Dyck, J. R. B. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.07.004 · Cited by 192
Self-citationMutation in PDE8B,a Cyclic AMP–Specific Phosphodiesterase in Adrenal Hyperplasia
Horvath, A., Mericq, V., & Stratakis, C. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0706182 · Cited by 190
Giampà, C., Laurenti, D., Anzilotti, S., Bernardi, G., Menniti, F. S., & Fusco, F. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013417 · Cited by 184
High affinity binding protein for the regulatory subunit of cAMP-dependent protein kinase II-B
Bregman, D. B., Bhattacharyya, N., & Rubin, C. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83792-9 · Cited by 183
Man, H.-W., Schafer, P., Wong, L. M., Patterson, R. T., Corral, L. G., Raymon, H., Blease, K., Leisten, J., Shirley, M. A., Tang, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900210d · Cited by 183
Ariga, M., Neitzert, B., Nakae, S., Mottin, G., Bertrand, C., Pruniaux, M. P., Jin, S.-L. C., & Conti, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7531 · Cited by 181
Ramamurthy, V., Niemi, G. A., Reh, T. A., & Hurley, J. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404197101 · Cited by 180
Cyclic Nucleotide Phosphodiesterases in Health and Disease
(2006) · CRC Press eBooks · doi:10.1201/9781420020847 · Cited by 173
Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
Shi, Z., Tiwari, A. K., Shukla, S., Robey, R. W., Singh, S., Kim, I.-W., Bates, S. E., Peng, X., Abraham, I., Ambudkar, S. V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3820 · Cited by 170
Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303269200 · Cited by 168
Multiple Conformations of Phosphodiesterase-5
Wang, H., Liu, Y., Huai, Q., Cai, J., Zoraghi, R., Francis, S. H., Corbin, J. D., Robinson, H. H., Xin, Z., Lin, G., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512527200 · Cited by 167
Self-citationThe Usefulness of Brain Natriuretic Peptide in Complex Congenital Heart Disease
Eindhoven, J. A., van den Bosch, A. E., Jansen, P. R., Boersma, E., & Roos-Hesselink, J. W. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.092 · Cited by 165
Stangherlin, A., Gesellchen, F., Zoccarato, A., Terrin, A., Fields, L. A., Berrera, M., Surdo, N. C., Craig, M. A., Smith, G., Hamilton, G., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.230698 · Cited by 165
Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
Richter, W., Day, P., Agrawal, R., Bruss, M. D., Granier, S., Wang, Y. L., Rasmussen, S. G. F., Horner, K., Wang, P., Lei, T., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601968 · Cited by 164
Self-citationA Complex between FAK, RACK1, and PDE4D5 Controls Spreading Initiation and Cancer Cell Polarity
Serrels, B., Sandilands, E., Serrels, A., Baillie, G. S., Houslay, M. D., Brunton, V. G., Canel, M., Machesky, L. M., Anderson, K. I., & Frame, M. C. (2010) · Current Biology · doi:10.1016/j.cub.2010.04.042 · Cited by 164
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy
Adamo, C. M., Dai, D.-F., Percival, J. M., Minami, E., Willis, M. S., Patrucco, E., Froehner, S. C., & Beavo, J. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013077107 · Cited by 162
Pandit, J., Forman, M. D., Fennell, K. F., Dillman, K. S., & Menniti, F. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907635106 · Cited by 160
Hansen, G., Jin, S.-L. C., Umetsu, D. T., & Conti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6751 · Cited by 154
Targeting cancer with phosphodiesterase inhibitors
Savai, R., Pullamsetti, S. S., Banat, G.-A., Weißmann, N., Ghofrani, H. A., Grimminger, F., & SCHERMULY, R. T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903485642 · Cited by 150
Leroy, J., Richter, W., Mika, D., Castro, L. R., Abi‐Gerges, A., Xie, M., Scheitrum, C., Lefebvre, F., Schittl, J., Matéo, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44747 · Cited by 149
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
Wunder, F., Tersteegen, A., Rebmann, A., Erb, C., Fahrig, T., & Hendrix, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017608 · Cited by 149
Stefan, E., Wiesner, B., Baillie, G. S., Mollajew, R., Henn, V., Lorenz, D., Furkert, J., Santamaria, K., Nedvetsky, P. I., Hundsrucker, C., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020132 · Cited by 148
Hutson, P. H., Finger, E. N., Magliaro, B. C., Smith, S. M., Converso, A., Sanderson, P. E. J., Mullins, D. E., Hyde, L. A., Eschle, B. K., Turnbull, Z., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.009 · Cited by 146
Wong, M., Whelan, F., Deloukas, P., Whittaker, P., Delgado, M., Cantor, R. M., McCann, S. M., & Licinio, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602795103 · Cited by 145
THE POTENTIATION OF CARDIAC INOTROPIC RESPONSES TO NOREPINEPHRINE BY THEOPHYLLINE
Rall, T. W., & West, T. C. (1963) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26490-4 · Cited by 144
Ke, H., & Wang, H. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941242 · Cited by 144
Self-citationThe Cardiac IKs Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3
Terrenoire, C., Houslay, M. D., Baillie, G. S., & Kass, R. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805366200 · Cited by 143
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF
Pullamsetti, S. S., Banat, G. A., Schmall, A., Szibor, M., Pomagruk, D., Hänze, J., Kołosionek, E., Wilhelm, J., Braun, T. W., Grimminger, F., et al. (2012) · Oncogene · doi:10.1038/onc.2012.136 · Cited by 143
Selective PDE inhibitors as novel treatments for respiratory diseases
Page, C. P., & Spina, D. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.016 · Cited by 143
A Phosphodiesterase 2A Isoform Localized to Mitochondria Regulates Respiration
Acín‐Pérez, R., Russwurm, M., Günnewig, K., Gertz, M., Zoidl, G., Ramos, L. S., Buck, J., Levin, L. R., Rassow, J., Manfredi, G., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266379 · Cited by 142
Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias
Molina, C. E., Leroy, J., Richter, W., Xie, M., Scheitrum, C., Lee, I.-O., Maack, C., Rücker‐Martin, C., Donzeau‐Gouge, P., Verde, I., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.060 · Cited by 142
Choi, Y.-H., Suzuki, A., Hajarnis, S., Ma, Z., Chapin, H. C., Caplan, M. J., Pontoglio, M., Somlo, S., & Igarashi, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016214108 · Cited by 139
Biochemical Basis of Asthma Therapy
Barnes, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.206466 · Cited by 136
Beca, S., Ahmad, F., Shen, W., Liu, J., Makary, S., Polidovitch, N., Sun, J., Hockman, S. C., Chung, Y. W., Movsesian, M. A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.300003 · Cited by 135
Self-citationPDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia
Fatemi, S. H., King, D. P., Reutiman, T. J., Folsom, T. D., Laurence, J. A., Lee, S. S., Fan, Y.-T., Paciga, S. A., Conti, M., & Menniti, F. S. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.029 · Cited by 134
Wittmann, M., & Helliwell, P. (2013) · Dermatology and Therapy · doi:10.1007/s13555-013-0023-0 · Cited by 132
Sachs, B. D., Baillie, G. S., McCall, J. R., Passino, M. A., Schachtrup, C., Wallace, D. A., Dunlop, A. J., MacKenzie, K. F., Klußmann, E., Lynch, M. J., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701040 · Cited by 132
Manallack, D. T., Hughes, R. A., & Thompson, P. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040217u · Cited by 132
Nagel, D. J., Aizawa, T., Jeon, K., Liu, W., Mohan, A. M., Wei, H., Miano, J. M., Florio, V. A., Gao, P., Korshunov, V. A., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000215576.27615.fd · Cited by 127
Hambleton, R., Krall, J., Tikishvili, E., Honeggar, M., Ahmad, F., Manganiello, V. C., & Movsesian, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506760200 · Cited by 125
Self-citationRegulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases
Potter, L. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.12.005 · Cited by 122
The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis,
Huai, Q., Colicelli, J., & Ke, H. (2003) · Biochemistry · doi:10.1021/bi034653e · Cited by 122
Self-citationBeneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
DeMarch, Z., Giampà, C., Patassini, S., Bernardi, G., & Fusco, F. R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.010 · Cited by 121
Libé, R., Horvath, A., Vezzosi, D., Fratticci, A., Coste, J., Perlemoine, K., Ragazzon, B., Guillaud-Bataille, M., Groussin, L., Clauser, É., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1704 · Cited by 121
PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
Kehler, J., & Nielsen, J. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049624 · Cited by 121
Wang, H., Peng, M.-S., Chen, Y., Geng, J., Robinson, H. H., Houslay, M. D., Cai, J., & Ke, H. (2007) · Biochemical Journal · doi:10.1042/bj20070970 · Cited by 120
Self-citationDual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
Banner, K. H., & Press, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00170.x · Cited by 119
Miller, C. L., Cai, Y., Oikawa, M., Thomas, T. N., Dostmann, W. R., Zaccolo, M., Fujiwara, K., & Chen, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0228-2 · Cited by 118
Functional compartmentation of cyclic AMP and protein kinase in heart.
Ll, B., Js, H., & Mayer, S. E. (1981) · PubMed · Cited by 117
Parkes, D. G., Mace, K. F., & TRAUTMANN, M. E. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.741580 · Cited by 116
Phosphodiesterase 1C is dispensable for rapid response termination of olfactory sensory neurons
Cygnar, K. D., & Zhao, H. (2009) · Nature Neuroscience · doi:10.1038/nn.2289 · Cited by 112
Cheng, Y., Wang, C., Lin, H.-B., Li, Y., Huang, Y., Xu, J., & Zhang, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1943-3 · Cited by 111
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors
Favot, L., Keravis, T. M., Holl, V., Bec, A. L., & Lugnier, C. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0084 · Cited by 110
Beca, S., Helli, P. B., Simpson, J. A., Zhao, D., Farman, G. P., Jones, P. P., Tian, X., Wilson, L. S., Ahmad, F., Chen, S. R. W., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.250464 · Cited by 110
Self-citationWouters, E. F. �., Bredenbröker, D., Teichmann, P., Brose, M., Rabe, K. F., Fabbri, L. M., & Göke, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2886 · Cited by 109
AKAPs: The architectural underpinnings of local cAMP signaling
Kritzer, M. D., Li, J., Dodge‐Kafka, K. L., & Kapiloff, M. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.002 · Cited by 109
McPhee, I., Yarwood, S. J., Scotland, G., Huston, E., Beard, M., Ross, A. H., Houslay, E. S., & Houslay, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11796 · Cited by 108
Differential Regulation of Endothelial Cell Permeability by cGMP via Phosphodiesterases 2 and 3
Surapisitchat, J., Jeon, K., Chen, Y., & Beavo, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.154229 · Cited by 108
Frank, C., Szaszák, M., Friedl, S., Drewianka, S., Lorenz, D., Gonçalves, A. C. D. C., Furkert, J., Vargas, C., Schmieder, P., Götz, F. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160614 · Cited by 107
Katakami, N., Kim, Y.-S., Kawamori, R., & Yamasaki, Y. (2010) · Circulation · doi:10.1161/circulationaha.109.892414 · Cited by 107
Kerfant, B., Zhao, D., Lorenzen‐Schmidt, I., Wilson, L. S., Cai, S., Chen, S. R. W., Maurice, D. H., & Backx, P. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.156422 · Cited by 106
Self-citationPDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model
Black, K. L., Yin, D., Ong, J. M., Hu, J., Konda, B. M., Wang, X., Ko, M. K., Bayan, J., Sacapano, M. R., Espinoza, A., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.122 · Cited by 106
Millar, J. K., Mackie, S., Clapcote, S. J., Murdoch, H., Pickard, B. S., Christie, S., Muir, W. J., Blackwood, D., Roder, J., Houslay, M. D., et al. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.140210 · Cited by 104
Sin, Y. Y., Edwards, H. V., Li, X., Day, J. P., Christian, F., Dunlop, A. J., Adams, D. R., Zaccolo, M., Houslay, M. D., & Baillie, G. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.006 · Cited by 103
Calzetta, L., Page, C. P., Spina, D., Cazzola, M., Rogliani, P., Facciolo, F., & Matera, M. G. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204644 · Cited by 102
Jin, S.-L. C., Goya, S., Nakae, S., Wang, D., Bruss, M. D., Hou, C., Umetsu, D. T., & Conti, M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.014 · Cited by 99
Castro, L. R., Schittl, J., & Fischmeister, R. (2010) · Circulation Research · doi:10.1161/circresaha.110.226712 · Cited by 99
Phosphodiesterase 7A-Deficient Mice Have Functional T Cells
Yang, G., McIntyre, K. W., Townsend, R. M., Shen, H., Pitts, W. J., Dodd, J. H., Nadler, S. G., McKinnon, M., & Watson, A. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6414 · Cited by 98
Dodge‐Kafka, K. L., Bauman, A. L., Mayer, N., Henson, E., Heredia, L., Ahn, J., McAvoy, T., Nairn, A. C., & Kapiloff, M. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034868 · Cited by 97
Ghigo, A., Perino, A., Mehel, H., Zahradníková, A., Morello, F., Leroy, J., Nikolaev, V. O., Damilano, F., Cimino, J. J., Luca, E. D., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.114074 · Cited by 97
Rothenbuhler, A., Horvath, A., Libé, R., Faucz, F. R., Fratticci, A., Raffin Sanson, M. L., Vezzosi, D., Azevedo, M., Levy, I., Almeida, M. Q., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04366.x · Cited by 96
Kleiman, R. J., Kimmel, L. H., Bove, S. E., Lanz, T. A., Harms, J. F., Romegialli, A., Miller, K. S., Willis, A. D., Etages, S. D., Kuhn, M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173294 · Cited by 94
PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome
Terrin, A., Monterisi, S., Stangherlin, A., Zoccarato, A., Koschinski, A., Surdo, N. C., Mongillo, M., Sawa, A., Jordanides, N. E., Mountford, J. C., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201201059 · Cited by 94
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Singh, D., Pétavy, F., MacDonald, A. J., Lazaar, A. L., & O'Connor, B. J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-26 · Cited by 90
Azzouni, F. S., & Abusamra, K. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02382.x · Cited by 86
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida, M. Q., & Stratakis, C. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.018 · Cited by 86
Kelly, M. P., Logue, S. F., Brennan, J. A., Day, J. P., Lakkaraju, S., Jiang, L., Zhong, X., Tam, M., Rizzo, S. J. S., Platt, B. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000730107 · Cited by 85
Begum, N., Hockman, S. C., & Manganiello, V. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214155 · Cited by 82
Self-citationZhang, R., Maratos–Flier, E., & Flier, J. S. (2009) · Endocrinology · doi:10.1210/en.2009-0108 · Cited by 80
DISC1, PDE4B, and NDE1 at the centrosome and synapse
Bradshaw, N. J., Ogawa, F., Antolin‐Fontes, B., Chubb, J. E., Carlyle, B. C., Christie, S., Claessens, A., Porteous, D. J., & Millar, J. K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.120 · Cited by 80
cAMP-Specific Phosphodiesterases 8A and 8B, Essential Regulators of Leydig Cell Steroidogenesis
Shimizu‐Albergine, M., Tsai, L.-C. L., Patrucco, E., & Beavo, J. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076125 · Cited by 80
Sub‐picomolar relaxin signalling by a pre‐assembled RXFP1, AKAP79, AC2, β‐arrestin 2, PDE4D3 complex
Halls, M. L., & Cooper, D. M. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.168 · Cited by 79
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers
Lin, D., Xu, L., Ding, L., Sharma, A., Liu, L.-Z., Yang, H. H., Tan, P. B. O., Vadgama, J. V., Karlan, B. Y., Lester, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218206110 · Cited by 78
Laddha, S. S., & Bhatnagar, S. P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.041 · Cited by 78
Mohamed, T., Oceandy, D., Zi, M., Prehar, S., Alatwi, N., Wang, Y., Shaheen, M. A., Abouleisa, R., Schelcher, C., Hegab, Z., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290411 · Cited by 78
Self-citationBlanton, R. M., Takimoto, E., Lane, A. M., Aronovitz, M. J., Piotrowski, R., Karas, R. H., Kass, D. A., & Mendelsohn, M. E. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003731 · Cited by 77
Tamhane, U. U., Meier, P., Chetcuti, S. J., Chen, K., Rha, S., Grossman, P. M., & Gurm, H. S. (2009) · EuroIntervention · doi:10.4244/v5i3a60 · Cited by 75
Re-Discovering PDE3 Inhibitors - New Opportunities for a Long Neglected Target
Thompson, P. E., Manganiello, V., & Degerman, E. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941224 · Cited by 74
Self-citationPenmatsa, H., Zhang, W., Yarlagadda, S., Li, C., Conoley, V. G., Yue, J., Bahouth, S. W., Buddington, R. K., Zhang, G., Nelson, D. J., et al. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-08-0655 · Cited by 73
Self-citationWilson, L. S., Elbatarny, H. S., Crawley, S. W., Bennett, B. M., & Maurice, D. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804738105 · Cited by 72
Self-citation3′,5′-Cyclic nucleotide phosphodiesterase 11A: localization in human tissues
Loughney, K., Taylor, J., & Florio, V. A. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901317 · Cited by 72
Signal integration through blending, bolstering and bifurcating of intracellular information
Pawson, C. T., & Scott, J. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1843 · Cited by 69
Tralau-Stewart, C. J., Williamson, R. A., Nials, A. T., Gascoigne, M. H., Dawson, J. A., Hart, G. J., Angell, A. D. R., Solanke, Y. E., Lucas, F. S., Wiseman, J. O., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173690 · Cited by 68
Davis, R. J., Tosi, J., Janisch, K. M., Kasanuki, J. M., Wang, N., Kong, J., Tsui, I. K., Cilluffo, M. C., Woodruff, M. L., Fain, G., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1422 · Cited by 67
Siuciak, J. A., McCarthy, S. A., Chapin, D. S., Reed, T. M., Vorhees, C. V., & Repaske, D. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.009 · Cited by 67
Levy, I., Horvath, A., Azevedo, M. F., de Alexandre, R. B., & Stratakis, C. A. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.003 · Cited by 67
Kim, H. W., Ha, S. H., Lee, M. N., Huston, E., Kim, D., Jang, S. K., Suh, P., Houslay, M. D., & Ryu, S. H. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00217-10 · Cited by 67
The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis
Tsai, L.-C. L., & Beavo, J. A. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.003 · Cited by 66
Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding mode
Kranz, M., Wall, M., Evans, B., Miah, A. H., Ballantine, S. P., Delves, C. J., Dombroski, B., Gross, J. W., Schneck, J. L., Villa, J. P., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.03.061 · Cited by 66
Beard, M., O’Connell, J. C., Bolger, G. B., & Houslay, M. D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01335-6 · Cited by 64
Meng, F., Hou, J., Shao, Y., Wu, P., Huang, M., Zhu, X., Cai, Y., Li, Z., Xu, J., Liu, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301189c · Cited by 64
Self-citationIdiopathic Dilated Cardiomyopathy
Luppi, P., Rudert, W. A., Zanone, M. M., Stassi, G., Trucco, G., Finegold, D. N., Boyle, G. J., del Nido, P. J., McGowan, F. X. J., & Trucco, M. (1998) · Circulation · doi:10.1161/01.cir.98.8.777 · Cited by 64
Shakur, Y., Fong, M., Hensley, J., Cone, J. L., Movsesian, M. A., Kambayashi, J., Yoshitake, M., & Liu, Y. (2002) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1022186402442 · Cited by 64
Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.
Kukreja, R. C., Salloum, F. N., Das, A., Koka, S., Ockaili, R. A., & Xi, L. (2011) · PubMed Central · Cited by 63
Wilson, L. S., Baillie, G. S., Pritchard, L. M., Umana, B., Terrin, A., Zaccolo, M., Houslay, M. D., & Maurice, D. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217026 · Cited by 62
Self-citationDual Acylation of PDE2A Splice Variant 3
Russwurm, C., Zoidl, G., Koesling, D., & Russwurm, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017194 · Cited by 62
Bregman, D. B., Hirsch, A. H., & Rubin, C. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89631-8 · Cited by 61
Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes
Dong, H., Osmanova, V., Epstein, P. M., & Brocke, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.143 · Cited by 61
Marko, D., Romanakis, K., Zankl, H., et al. (1998) · Cell Biochemistry and Biophysics · doi:10.1007/bf02737806 · Cited by 61
Phosphodiesterase-8A binds to and regulates Raf-1 kinase
Brown, K. M., Day, J. P., Huston, E., Zimmermann, B., Hampel, K., Frank, C., Romano, D., Terhzaz, S., Lee, L. C. Y., Willis, M. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303004110 · Cited by 61
Nishioka, K., Nishida, M., Ariyoshi, M., Zhong, J., Saiki, S., Hirano, M., Nakaya, M., Sato, Y., Kita, S., Iwamoto, T., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221010 · Cited by 61
Molenaar, P., Christ, T., Hussain, R. I., Engel, A., Berk, E., Gillette, K., Chen, L., Galindo‐Tovar, A., Krobert, K. A., Ravens, U., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12167 · Cited by 60
Lee, L. C. Y., Maurice, D. H., & Baillie, G. S. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.216 · Cited by 60
Self-citationCreighton, J. R., Zhu, B., ALEXEYEV, M. F., & Stevens, T. (2007) · Journal of Cell Science · doi:10.1242/jcs.011692 · Cited by 57
Roles of Sildenafil in Enhancing Drug Sensitivity in Cancer
Shi, Z., Tiwari, A. K., Patel, A. S., Fu, L., & Chen, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0375 · Cited by 56
Putting the lid on phosphodiesterase 4
Houslay, M. D., & Adams, D. R. (2010) · Nature Biotechnology · doi:10.1038/nbt0110-38 · Cited by 54
Palmer, D., Jimmo, S. L., Raymond, D. R., Wilson, L. S., Carter, R. L., & Maurice, D. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606936200 · Cited by 54
Self-citationPhosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428
Rubio, M. P., Campbell, D. G., Morrice, N. A., & MacKintosh, C. (2005) · Biochemical Journal · doi:10.1042/bj20051103 · Cited by 51
Ahmad, F., Lindh, R., Tang, Y., Weston, M. C., Degerman, E., & Manganiello, V. C. (2007) · Biochemical Journal · doi:10.1042/bj20060960 · Cited by 50
Self-citationTsai, L.-C. L., Chan, G. C. ‐., Nangle, S. N., Shimizu‐Albergine, M., Jones, G. L., Storm, D. R., Beavo, J. A., & Zweifel, L. S. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00836.x · Cited by 49
Signaling from β1‐ and β2‐adrenergic receptors is defined by differential interactions with PDE4
Richter, W., Day, P., Agrawal, R., Bruss, M. D., Granier, S., Wang, Y. L., Rasmussen, S. G. F., Horner, K., Wang, P., Lei, T., et al. (2008) · The FASEB Journal · doi:10.1096/fasebj.22.1_supplement.1046.7 · Cited by 48
Self-citationTenor, H., Hatzelmann, A., Beume, R., Lahu, G., Zech, K., & Bethke, T. D. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_3 · Cited by 46
Phosphodiesterase Inhibitors: History of Pharmacology
Schudt, C., Hatzelmann, A., Beume, R., & Tenor, H. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_1 · Cited by 46
Zhang, M., Takimoto, E., Lee, D., Santos, C. X. C., Nakamura, T., Hsu, S., Jiang, A., Nagayama, T., Bedja, D., Yuan, Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.090977 · Cited by 46
Huston, E., Gall, I., Houslay, T. M., & Houslay, M. D. (2006) · Journal of Cell Science · doi:10.1242/jcs.03106 · Cited by 46
PDE5 inhibitors: targeting erectile dysfunction in diabetics
Francis, S. H., & Corbin, J. D. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.08.004 · Cited by 46
Frank, C., Anthony, D. F., Vadrevu, S., Riddell, T., Day, J. P., McLeod, R., Adams, D. R., Baillie, G. S., & Houslay, M. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.06.003 · Cited by 43
Kadoshima-Yamaoka, K., Murakawa, M., Goto, M., Tanaka, Y., Inoue, H., Murafuji, H., Nagahira, A., Hayashi, Y., Nagahira, K., Miura, K., et al. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.01.004 · Cited by 43
Liddie, S., Anderson, K. L., Paz, A., & Itzhak, Y. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112447991 · Cited by 43
Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159
Oh, T. Y., Kang, K. K., Ahn, B. O., Yoo, M., & Kim, W. B. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976575 · Cited by 42
Wang, H., Robinson, H. H., & Ke, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141614 · Cited by 40
Self-citationGiembycz, M. A., & Newton, R. C. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_18 · Cited by 40
Phosphodiesterase 11 (PDE11): is it a player in human testicular function?
Francis, S. H. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901377 · Cited by 36
Geng, D.-F., Deng, J., Jin, D., Wu, W., & Wang, J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.048 · Cited by 36
PDE inhibitors: a new approach to treat metabolic syndrome?
Lugnier, C. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.012 · Cited by 36
Boden, W. E., Finn, A. V., Patel, D. D., Peacock, W. F., Thadani, U., & Zimmerman, F. H. (2012) · Clinical Cardiology · doi:10.1002/clc.21993 · Cited by 35
Cited by
Regulation of tumour necrosis factor signalling: live or let die
Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Li, L., Yin, Q., Kuss, P., Maliga, Z., Millán, J. L., Wu, H., & Mitchison, T. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1661 · Cited by 533
Transcriptional Architecture of Synaptic Communication Delineates GABAergic Neuron Identity
Paul, A., Crow, M., Raudales, R., He, M., Gillis, J., & Huang, Z. J. (2017) · Cell · doi:10.1016/j.cell.2017.08.032 · Cited by 421
Molecular Physiology of Membrane Guanylyl Cyclase Receptors
Kuhn, M. (2016) · Physiological Reviews · doi:10.1152/physrev.00022.2015 · Cited by 356
Metadata
- Authors
- Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-04
- Volume
- 13
- Issue
- 4
- Pages
- 290-314
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1972029787
- Cited by
- 776
- References
- 222
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.